Skip to content

JBIO JBIO Total Assets

Total Assets at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$26.48B+15.8%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$555.19M+1.2%
Vera Therapeutics logo
Vera TherapeuticsVERA
$621.74M+1.9%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$329.68M-21.9%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$402.98M-30.5%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$789.02M+19.4%

Other financials

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%

Cash flow

See full
Operating cash flow-$24.1M-28.4%
CapEx$3.0K
Free cash flow-$33.7M

Valuation

See full
Market cap$1.33B
Enterprise value$1.28B

Returns & leverage

See full
Return on equity-132.5%+120pp
Debt / equity
Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is JBIO's total assets?
JBIO (JBIO) reported total assets of $319.43M in Q1 2026.
How has JBIO's total assets changed year-over-year?
JBIO's total assets increased by 312.0% year-over-year, from $77.53M to $319.43M.
What is the long-term trend for JBIO's total assets?
Over 5 years (2020 to 2025), JBIO's total assets has grown at a 136.6% compound annual growth rate (CAGR), from $4.72M to $349.78M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.